MarketCenter for Autism and Related Disorders
Company Profile

Center for Autism and Related Disorders

The Center for Autism and Related Disorders, Inc. (CARD) is a business that administers applied behavior analysis (ABA) to autistic people.

History
CARD was founded in 1990 by Doreen Granpeesheh, a former graduate student of Ole Ivar Løvaas, the UCLA psychology professor who popularized the use of ABA on autistic children. Acquisition by Blackstone (2018–2019) In May 2018, the Blackstone Group acquired CARD in a leveraged buyout valued at approximately US$600–700 million, one of the largest transactions in the behavioral-health sector. Granpeesheh stepped down as CEO in 2019 but remained on the company’s board. Blackstone planned to scale CARD to over 500 clinics using data analytics and centralized management. Former staff later reported that after the acquisition, corporate leadership reduced centralized clinical training and replaced experienced clinicians with managers from outside behavioral health, leading to concerns about quality of care and high employee turnover. Ethical and clinical concerns The COVID-19 pandemic disrupted in-person services, and CARD’s telehealth expansion proved unsustainable. Critics and former staff alleged that under private equity ownership, clinical practices were increasingly standardized and profit-driven, reducing individualized care. CARD’s practices under private equity ownership were criticized for: • Inflating treatment hours to maximize billing. • Reducing supervision ratios (1 BCBA per 25–30 clients). • Prioritizing preschool-age clients with higher insurance reimbursement. These trends reflected a broader pattern of “financialization of care” identified by a CEPR report In June 2023, CARD filed for Chapter 11 bankruptcy protection, reporting US$82 million in losses and US$245 million in debt. The CEPR report concluded that Blackstone’s debt-loading and overexpansion turned CARD from a sustainable clinic network into “a cautionary example of financialized health care.” == Legacy ==
Legacy
CARD is widely recognized for establishing ABA as the predominant evidence-based treatment for autism. Its research initiatives and software platforms, such as Skills, influenced global clinical training and insurance models. While CARD’s model is credited with expanding access to autism treatment, it has been criticized by neurodiversity advocates for promoting intensive behavioral modification and neglecting autistic self-advocacy perspectives. ==Documentary==
Documentary
CARD co-produced (with Granpeesheh) and distributed Recovered: Journeys Through the Autism Spectrum and Back, a 2008 documentary about four children that the organization claims completely "recovered" from autism and co-occurring intellectual disability as a result of the intensive, longterm ABA they administered, despite the fact that there is no known cure for autism. In the film, Granpeesheh stated, "There's a lot of scientific research that shows children recover from autism, and yet, still, the medical community in general is not aware of how prevalent recovery is. More than half of the children receiving intervention at an early age recover completely." ==References==
tickerdossier.comtickerdossier.substack.com